SEC Form 4 · accession 0001104659-17-038156
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rahul Dhanda
Officer — SVP of Corporate Development
Period of report
Jun 6, 2017
Accepted (ET)
Jun 8, 2017 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 6, 2017 | M | 3,000 | $0.48 | A | 4,667 | D | |
| Common Stock | Jun 6, 2017 | P | 1,000 | $3.50 | A | 5,667 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.48 | Jun 6, 2017 | M | 3,000 | D | Feb 20, 2012 | Feb 20, 2018 | Common Stock | 3,000 | 0 | D |
Explanation of responses
- F1Includes 1,667 shares acquired under the Issuer's employee stock purchase plan on April 30, 2015, which were inadvertently omitted from the reporting person's subsequent Forms 4.